The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin And Rivaroxaban In The Treatment Of Acute Pulmonary Embolism In The Uk
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1440
https://www.valueinhealthjournal.com/article/S1098-3015(14)03370-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
925
First Page :
A489
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03370-1&doi=10.1016/j.jval.2014.08.1440